Similar articles

• Histocompatibility determinants in multiple sclerosis.

  Jersild C, Dupont B, Fog T, Platz PJ, Svejgaard A. Jersild C, et al. Transplant Rev. 1975;22:148-63. doi: 10.1111/j.1600-065x.1975.tb01556.x. Transplant Rev. 1975. PMID: 46643 No abstract available.
• Familial multiple sclerosis: clinical, histocompatibility, and viral serological studies.

  Eldridge R, McFarland H, Sever J, Sadowsky D, Krebs H. Eldridge R, et al. Ann Neurol. 1978 Jan;3(1):72-80. doi: 10.1002/ana.410030111. Ann Neurol. 1978. PMID: 418737
• Measles antibody titers in multiple sclerosis patients and HLA-matched and unmatched siblings.

  Visscher BR, Sullivan CB, Detels R, Madden DL, Sever JL, Terasaki PI, Park MS, Dudley JP. Visscher BR, et al. Neurology. 1981 Sep;31(9):1142-5. doi: 10.1212/wnl.31.9.1142. Neurology. 1981. PMID: 6267516
• HL-A and disease associations--a survey.

  Svejgaard A, Platz P, Ryder LP, Nielsen LS, Thomsen M. Svejgaard A, et al. Transplant Rev. 1975;22:3-43. doi: 10.1111/j.1600-065x.1975.tb01550.x. Transplant Rev. 1975. PMID: 46644 Review. No abstract available.
• Family and twin studies in multiple sclerosis.

  McFarland HF, Greenstein J, McFarlin DE, Eldridge R, Xu XH, Krebs H. McFarland HF, et al. Ann N Y Acad Sci. 1984;436:118-24. doi: 10.1111/j.1749-6632.1984.tb14782.x. Ann N Y Acad Sci. 1984. PMID: 6398014 Review. No abstract available.